Amgen Achieves A First With European Eculizumab Nod

Bekemv Biosimilar Rival To Soliris Receives Positive Opinion From EMA’s CHMP

 
• By David Wallace
  
EMA
The EMA’s CHMP has endorsed Amgen’s eculizumab rival
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products